SUBSCRIBE
SUBSCRIBE

Phase I

Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Watch Out, Ionis Pharma: Could This Little Biotech’s Experimental SMA Treatment Be a Threat?
October 14, 2016
 · 
2 min read
ESMO 2016 Takeaways: Don't Miss Celldex, Exelixis and Tesaro
Drug Development
ESMO 2016 Takeaways: Don’t Miss Celldex, Exelixis and Tesaro
October 12, 2016
 · 
3 min read
Drug Development
Ventrix’s Shows Early Signs Of Helping Heart Attack Healing
October 10, 2016
 · 
1 min read
Drug Development
4 Small Biotechs That Could Give Gilead, Merck & Co. Pfizer Some Competition With NASH
October 7, 2016
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
A Closer Look at the Pipelines Pfizer Inherited From Recent Acquisitions
October 5, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Massachusetts’s Alnylam Falls After Stopping Development of RNAi Liver Disease Candidate ALN-AAT
September 30, 2016
 · 
2 min read
Gilead Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency
Drug Development
Gilead to Release Data on 9 Clinical Trials Before End of the Year
September 16, 2016
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
10 Biotechs—Count ‘Em, 10!—With Big Decisions in the Fourth Quarter
September 12, 2016
 · 
4 min read
Juno Was Being Wooed to the Big Apple But Here's Why It's Staying in Seattle
Drug Development
Juno Surges as Small Cancer Study is Hailed a Success, Shows Promise for Other Drugs
September 8, 2016
 · 
2 min read
Drug Development
FDA: Toxicity Seen In Fatal French Study Does Not Extend To Other FAAH Inhibitors
August 15, 2016
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Nuvectis Pharma Announces FDA Clearance of NXP900 IND
May 15, 2023
 · 
5 min read
Drug Development
Protara Therapeutics Announces Dosing of First Patients in Phase 1b ADVANCED-1EXP Trial of TARA-002 in NMIBC Patients with Carcinoma in Situ
May 15, 2023
 · 
6 min read
Drug Development
Numab Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of NM26 Program
May 15, 2023
 · 
5 min read
Drug Development
TILT Biotherapeutics Announces First Patient Dosed in Phase I Solid Tumors Trial Assessing Oncolytic Adenovirus TILT-123 in Combination with Checkpoint Inhibitor
May 15, 2023
 · 
3 min read
Drug Development
Upstream Bio to Present New Clinical Data from Phase 1 Study of UPB-101 at the American Thoracic Society (ATS) International Conference
May 12, 2023
 · 
3 min read
Drug Development
Protagonist Reports Positive Results from Phase 1 and Pre-clinical Studies of Oral Interleukin-23 Receptor Antagonist JNJ-2113
May 12, 2023
 · 
6 min read
Drug Development
Celcuity Presents Updated Results from Phase 1b Study of Gedatolisib in Treatment-Naïve Patients at the 2023 ESMO Breast Cancer Annual Congress
May 12, 2023
 · 
6 min read
Drug Development
Mustang Bio Announces Upcoming Presentations of Clinical Data from Phase 1/2 Trial of MB-106, a CD20-Targeted Autologous CAR T Cell Therapy
May 11, 2023
 · 
5 min read
Drug Development
Nkarta to Present NKX019 Phase 1 Dose Escalation Data at European Hematology Association 2023 Congress and 17th International Conference on Malignant Lymphoma
May 11, 2023
 · 
4 min read
Drug Development
Allogene Therapeutics Announces Encore Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the European Hematology Association (EHA) Hybrid Congress
May 11, 2023
 · 
5 min read
Drug Development
cGMP Manufacturing Complete for Lexaria’s Upcoming U.S. Phase 1b Hypertension Clinical Trial
May 11, 2023
 · 
6 min read
Drug Development
Results of Phase I Clinical Study of Qilu Pharma’s PD-1/CTLA-4 Bifunctional Antibody Iparomlimab/Tuvonralimab Published Online in Journal of Hematology & Oncology
May 11, 2023
 · 
4 min read
Drug Development
Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study
May 11, 2023
 · 
7 min read
Drug Development
Onconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer
May 11, 2023
 · 
6 min read
Drug Development
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4021586Advancement of Additional Cardiac Myosin Inhibitor Expands Specialty Cardiovascular Portfolio
May 11, 2023
 · 
4 min read
Drug Development
Extend Biosciences Announces Positive Data from Phase 1 Trial of EXT608 for the Treatment of Hypoparathyroidism
May 11, 2023
 · 
4 min read
Drug Development
Monopar Therapeutics Reports First Quarter 2023 Financial Results and Recent Developments
May 11, 2023
 · 
9 min read
Drug Development
Indaptus Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 11, 2023
 · 
13 min read
Drug Development
Praxis Precision Medicines Announces Positive Topline Results from PRAX-628 Phase 1 Study Enabling Best-in-Class Profile
May 11, 2023
 · 
5 min read
Drug Development
Nuvalent Announces Anticipated Timing of Preliminary Phase 1 Dose-Escalation Data for NVL-655 and Reports First Quarter 2023 Financial Results
May 11, 2023
 · 
8 min read
Load More